SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891092-04-003937
Filing Date
2004-08-06
Accepted
2004-08-06 15:14:33
Documents
5
Period of Report
2004-08-06
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e18754_8k.txt 8-K 3593
2 SECURITIES PURCHASE AGREEMENT e18754ex10-1.txt EX-10.1 77560
3 FORM OF WARRANT e18754ex10-2.txt EX-10.2 42929
4 REGISTRATION RIGHTS AGREEMENT e18754ex10-3.txt EX-10.3 51116
5 PRESS RELEASE e18754ex99-1.txt EX-99.1 4922
  Complete submission text file 0000891092-04-003937.txt   182247
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13441 | Film No.: 04957797
SIC: 2836 Biological Products, (No Diagnostic Substances)